Source: Annual Congress 2004 - Clinical and related features in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Bartu, E. Kopecka (Prague, Czech Republic). Cause and outcome of relapse of tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 1268

Member's Comments

No comment yet.

Related content which might interest you: Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Failure of diagnosis in tuberculosis mortality Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Evaluation of relapse and defaulter pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Who are at risk for tuberculosis recurrence? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 Risk factors for relapses of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003 Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Prognosis and predictors for mortality in patients with tuberculosis destroyed lung Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Causes of therapeutical failure in tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003 Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal Source: Eur Respir J 2013; 42: 1747-1749 Year: 2013 Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Clinical presentation and mortality of tuberculosis in the elderly Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis Source: Annual Congress 2010 - Tuberculosis and HIV coinfection Year: 2010 Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study Source: Eur Respir J 2006; 28: 980-985 Year: 2006 Treatment and outcome of CRF patients with tuberculosis Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Causes of delay in the diagnosis of pulmonary tuberculosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Treatment effectiveness and predictors of poor outcome in MDR-TB and XDR-TB Source: Breathe 2008; 6: 161 Year: 2009